CEACAM5 and cervical carcinoma: The difference of CA19-9 and CEA levels between healthy controls and early-stage cervical cancer patients was found not significant (p = 0.71 and 0.17, respectively), indicating that CA19-9 or CEA alone cannot discriminate early-stage cervical cancer patients from healthy controls.